Trials / Completed
CompletedNCT01733732
SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers
Study to Evaluate the Efficacy of SYSTANE® BALANCE in Reducing Symptoms and Inflammatory Biomarker Expression of HLA-DR and Tear Film Cytokines in Dry Eye Subjects With Lipid Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the ability of SYSTANE® BALANCE and SYSTANE® Gel to improve comfort in subjects with dry eyes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SYSTANE® BALANCE Lubricant Eye Drops | |
| OTHER | SYSTANE® Gel |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-11-27
- Last updated
- 2018-06-29
- Results posted
- 2014-11-04
Source: ClinicalTrials.gov record NCT01733732. Inclusion in this directory is not an endorsement.